Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Developing an opioid use disorder treatment cascade: A review of quality measures.
Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M. Williams AR, et al. Among authors: friedmann pd. J Subst Abuse Treat. 2018 Aug;91:57-68. doi: 10.1016/j.jsat.2018.06.001. Epub 2018 Jun 2. J Subst Abuse Treat. 2018. PMID: 29910015 Free PMC article. Review.
Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision.
Allen AA, Chen DT, Bonnie RJ, Ko TM, Suratt CE, Lee JD, Friedmann PD, Gordon M, McDonald R, Murphy SM, Boney TY, Nunes EV, O'Brien CP. Allen AA, et al. Among authors: friedmann pd. J Subst Abuse Treat. 2017 Oct;81:66-72. doi: 10.1016/j.jsat.2017.07.015. Epub 2017 Aug 1. J Subst Abuse Treat. 2017. PMID: 28847457 Free PMC article. Clinical Trial.
Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68].
Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M. Williams AR, et al. Among authors: friedmann pd. J Subst Abuse Treat. 2018 Sep;92:99. doi: 10.1016/j.jsat.2018.06.015. Epub 2018 Jul 9. J Subst Abuse Treat. 2018. PMID: 30032951 No abstract available.
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.
Murphy SM, Polsky D, Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Bonnie RJ, Gordon M, Chen DT, Boney TY, O'Brien CP. Murphy SM, et al. Among authors: friedmann pd. Addiction. 2017 Aug;112(8):1440-1450. doi: 10.1111/add.13807. Epub 2017 Apr 12. Addiction. 2017. PMID: 28239984 Free PMC article. Clinical Trial.
Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual.
Soares WE 3rd, Wilson D, Gordon MS, Lee JD, Nunes EV, O'Brien CP, Shroff M, Friedmann PD. Soares WE 3rd, et al. Among authors: friedmann pd. Drug Alcohol Depend. 2019 Jan 1;194:482-486. doi: 10.1016/j.drugalcdep.2018.10.035. Epub 2018 Dec 3. Drug Alcohol Depend. 2019. PMID: 30522048 Free PMC article. Clinical Trial.
271 results